Cancer Drug May Have Promising Application For Mesothelioma Patients

Despite the unfortunate fact that mesothelioma is an incurable disease, there are a greater number of patients who are living longer lives with a greater quality of life. NBC News reports that a new drug produced by Novartis has been extremely successful in treating those suffering from chronic myelogenous leukemia (CML). The new drug, Gleevec helped 83% of CML patients taking the drug, live for an additional 10 years with minimal side-effects.

Gleevec was used as an alternative to the highly toxic chemotherapy treatment protocol typically used. The Novartis study was so successful that the clinical studies were halted so that all patients could receive the FDA approved drug.

While the drug has not yet been used in mesothelioma yet there is some hope that it will have applications for the asbestos caused disease based on similarities in treatment protocols.

The Paul Law Firm advocates for victims of asbestos-related diseases. If you or a loved one is suffering from mesothelioma, call the Paul Law Firm. With over 2.5 billion dollars collected for victims of asbestos exposure, we have the knowledge and the experience to fight for you. We also understand that fighting doesn’t just happen in the courtroom. It also happens in a lab where we are fighting for a cure. Check out the Mesothelioma Research Foundation of America here.

Call us today at 1-855 88 LEGAL (885-3425) or contact us online to discuss your case with one of our experienced mesothelioma lawyers.